SEC Info - Xylem Inc.

SEC Info℠

Home

My Interests

Help

Please Sign In

Xylem Inc.
DC
SEC # 1524472

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

*As Of*	*Filing*	*Page*	*Title*	*Docs.*

4/11/23	424B3	1	A- 11	2
		1	A- 2	2
		1	A- 4	2
		1	A- 6	2
		1	A- 7	2
		1	A- 8	2
		1	A- 9	2
		1	A-1	2
		1	A-10	2
		1	A-12	2
		1	A-13	2
		1	A-14	2
		1	A-15	2
		1	A-16	2
		1	A-17	2
		1	A-18	2
		1	A-19	2
		1	A-20	2
		1	A-21	2
		1	A-22	2
		1	A-23	2
		1	A-24	2
		1	A-25	2
		1	A-26	2
		1	A-27	2
		1	A-28	2
		1	A-29	2
		1	A-32	2
		1	A-38	2
		1	A-39	2
		1	A-40	2
		1	A-41	2
		1	A-42	2
		1	A-43	2
		1	A-44	2
		1	A-45	2
		1	A-46	2
		1	A-47	2
		1	A-48	2
		1	A-50	2
		1	A-51	2
		1	A-52	2
		1	A-54	2
		1	A-55	2
		1	A-56	2
8/3/23	S-3ASR	1	About the Registrant	1
		1	About This Prospectus	1
4/11/23	424B3	1	Absence of Certain Changes or Events	2
		1	Abstentions and Broker Non-Votes	2
		1	Access to Information; Confidentiality	2
		1	Accounting for the Merger	2
		1	Accounting Treatment of the Merger	2
4/2/24	DEF 14A	1	Additional Compensation Elements	2
		1	Additional Information	2
4/11/23	424B3	1	Adjustments to the Merger Consideration	2
		1	Amendment or Supplement	2
		1	Amendment or Supplement; Extension of Time; Waiver	2
10/31/23	10-Q	1	And	2
5/4/23	10-Q	1	And 202	1
10/31/23	10-Q	1	And 2022 (Unaudited)	2
5/4/23	10-Q	1	And December 31, 202	1
8/4/23	10-Q	1	And Six Months	1
		1	And Six Months Ended June 30, 2023	1
4/11/23	424B3	1	Annex A-Merger Agreement	2
		1	Annex B-Opinion of Goldman Sachs & Co. Llc	2
		1	ANNEX C-OPINION OF BofA SECURITIES, INC	2
		1	Annex D-Opinion of Lazard Freres & Co. Llc	2
		1	Annex E-Opinion of Guggenheim Securities, Llc	2
		1	Anti-Takeover Provisions of the Xylem Charter, Xylem Bylaws and Indiana Law	2
4/2/24	DEF 14A	1	Appendix A	1
4/11/23	424B3	1	Appraisal Rights	2
		1	Article I the Merger	2
		1	Article Ii Effect on the Capital Stock of the Constituent Corporations; Exchange of Certificates	2
		1	Article Iii Representations and Warranties of the Company	2
		1	Article Iv Representations and Warranties of Parent and Merger Sub	2
		1	Article V Covenants	2
		1	Article Vi Conditions Precedent	2
		1	Article Vii Termination, Amendment and Waiver	2
		1	Article Viii General Provisions	2
		1	Assignment; Successors	2
		1	Assistance	2
4/2/24	DEF 14A	1	Audit Committee Report	2
4/11/23	424B3	1	Authority	2
		1	B- 1	2
		1	Background of the Merger	2
		1	Benefit Plans	2
4/2/24	DEF 14A	1	Best Practices	2
		1	Board Committees	2
		1	Board Composition and Refreshment	2
		1	Board Effectiveness	2
		1	Board Leadership Structure	2
		1	Board Meetings	2
2/28/24	10-K	1	Board of Directors	1
4/11/23	424B3	1	Brokers	2
2/28/24	10-K	1	Business	1
4/3/23	DEF 14A	1	Business Performance for 202	1
4/2/24	DEF 14A	1	Business Performance for 2023	1
4/11/23	424B3	1	C- 1	2
		1	Capital Stock	2
		1	Cautionary Statement Regarding Forward-Looking Statements	2
4/2/24	DEF 14A	1	CEO Pay Ratio	2
		1	CEO Pay-for-Performance Summary	2
		1	Certain Beneficial Owners	2
4/11/23	424B3	1	Certain Definitions	2
		1	Certain Information	2
		1	Certain Payments	2
2/28/24	10-K	1	Certain Relationships and Related Transactions, and Director Independence	1
4/11/23	424B3	1	Certain Tax Matters	2
		1	Certain Unaudited Forecasted Financial Information	2
		1	Certificate of Incorporation; Bylaws	2
2/28/24	10-K	1	Changes In and Disagreements With Accountants on Accounting and Financial Disclosure	1
4/11/23	424B3	1	Closing	2
		1	Closing; Effective Time	2
4/2/24	DEF 14A	1	Commitment to Sustainability	2
		1	Communicating with the Board of Directors	2
4/11/23	424B3	1	Comparative Per Share Market Value	2
		1	Comparative Per Share Market Value and Dividend Information	2
		1	Comparison of Stockholders' and Shareholders' Rights	2
4/2/24	DEF 14A	1	Compensation Decision-Making Process	2
		1	Compensation Discussion and Analysis	2
4/11/23	424B3	1	Compliance with Laws	2
10/31/23	10-Q	1	Condensed Consolidated Balance Sheets as of	3
5/4/23	10-Q	1	Condensed Consolidated Income Statements for the Three	1
8/4/23	10-Q	1	Condensed Consolidated Income Statements for the Three Months	1
10/31/23	10-Q	1	Condensed Consolidated Income Statements for the Three Months and	1
		1	Condensed Consolidated Statements of Cash Flows for the	3
5/4/23	10-Q	1	Condensed Consolidated Statements of Comprehensive Income for the Three	1
10/31/23	10-Q	1	Condensed Consolidated Statements of Comprehensive Income for the Three Months	2
4/11/23	424B3	1	Conditions Precedent	2
		1	Conditions to Each Party's Obligation to Effect the Merger	2
		1	Conditions to the Obligations of Parent and Merger Sub	2
		1	Conditions to the Obligations of the Company	2
		1	Conduct of Business	2
		1	Consideration to Evoqua Stockholders	2
2/28/24	10-K	1	Consolidated Balance Sheets as of December 31, 2023 and 2022	1
		1	Consolidated Income Statements for the Years Ended December 31, 2023, 2022 and 2021	1
		1	Consolidated Statements of Cash Flows for the Years Ended December 31, 2023, 2022 and 2021	1
		1	Consolidated Statements of Changes in Stockholders' Equity for the Years Ended December 31, 2023, 2022 and 2021	1
		1	Consolidated Statements of Comprehensive Income for the Years Ended December 31, 2023, 2022 and 2021	1
4/11/23	424B3	1	Contracts	2
2/28/24	10-K	1	Controls and Procedures	4
4/11/23	424B3	1	Conversion of Capital Stock	2
4/2/24	DEF 14A	1	Corporate Governance	2
		1	Corporate Governance Policies and Practices	2
		1	Corporate Governance Principles	2
4/11/23	424B3	1	Counterparts	2
		1	Covenants	2
		1	Currency	2
		1	Customers	2
		1	D-1	2
		1	Data Privacy and Cybersecurity	2
		1	Date, Time and Place	2
6/26/23	11-K	1	December	1
10/31/23	10-Q	1	Defaults Upon Senior Securities	3
8/3/23	S-3ASR	1	Description of Common Stock	1
		1	Description of Debt Securities	1
		1	Description of Other Securities	1
4/11/23	424B3	1	Description of the Merger	2
		1	Description of Xylem Capital Stock	2
		1	Description of Xylem Common Stock	2
4/2/24	DEF 14A	1	Director Compensation	2
		1	Director Independence	2
4/11/23	424B3	1	Directors	2
4/2/24	DEF 14A	1	Directors and Named Executive Officers	2
4/11/23	424B3	1	Directors' and Officers' Indemnification and Insurance	2
2/28/24	10-K	1	Directors, Executive Officers and Corporate Governance	1
		1	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	1
4/11/23	424B3	1	Dividend and Liquidation Rights	2
		1	Dividend Information	2
		1	Dividend Policy	2
		1	Dividends and Distributions	2
		1	E- 1	2
		1	Effect of Termination	2
		1	Effective Time	2
		1	Effects of the Merger	2
10/31/23	10-Q	1	Ember	1
4/11/23	424B3	1	Employee Matters	2
8/4/23	10-Q	1	Ended	1
4/11/23	424B3	1	Entire Agreement; No Other Representations	2
		1	Environmental Matters	2
4/2/24	DEF 14A	1	Equity Compensation Plan Information	2
4/11/23	424B3	1	Evoqua	2
		1	Evoqua Proposal 1-The Merger Proposal	2
		1	Evoqua Proposal 2-The Advisory Compensation Proposal	2
		1	Evoqua Proposal 3-The Evoqua Adjournment Proposal	2
		1	Evoqua SEC Filings	2
		1	Evoqua Special Meeting	2
		1	Evoqua Special Meeting, The	2
		1	Evoqua Water Technologies Corp	2
		1	Exchange and Payment	2
		1	Exchange of Shares in the Merger	2
2/28/24	10-K	1	Executive Compensation	1
4/2/24	DEF 14A	1	Executive Summary	2
10/31/23	10-Q	1	Exhibits	3
3/31/23	S-4/A	1	Exhibits and Financial Statement Schedules	1
2/28/24	10-K	1	Exhibits, Financial Statement Schedules	1
4/11/23	424B3	1	Expenses	2
8/3/23	S-3ASR	1	Experts	3
4/11/23	424B3	1	Explanatory Note Regarding the Merger Agreement	2
		1	Extension of Time; Waiver	2
		1	Facsimile or .pdf Signature	2
		1	Failure to Vote	2
		1	Fees and Expenses	2
10/31/23	10-Q	1	Financial Statements	3
2/28/24	10-K	1	Financial Statements and Supplementary Data	1
4/11/23	424B3	1	Financing Cooperation	2
		1	Financing Matters	2
		1	Fore Merger Sub, Inc	2
2/28/24	10-K	1	Form 10-K Summary	1
6/26/23	11-K	1	Form 5500, Schedule H, Line 4i -- Schedule of Assets (Held at End of Year) as of December 31	1
4/11/23	424B3	1	Frustration of Closing Conditions	2
		1	General	2
		1	Governance Matters	2
		1	Governance of Xylem After Consummation of the Merger	2
		1	Governing Law	2
		1	Governing Law; Submission to Jurisdiction	2
		1	Government Contracts	2
4/2/24	DEF 14A	1	Grants of Plan-Based Awards	2
4/11/23	424B3	1	Householding of Evoqua Special Meeting Materials	2
		1	Householding of Proxy Materials	2
		1	Householding of Xylem Special Meeting Materials	2
3/31/23	S-4/A	1	Ii- 1	1
		1	Ii- 2	1
8/3/23	S-3ASR	1	Incorporation by Reference	1
3/31/23	S-4/A	1	Indemnification of Directors and Officers	1
4/11/23	424B3	1	Indemnification, Exculpation and Insurance	2
2/28/24	10-K	1	Information about our Executive Officers	1
4/11/23	424B3	1	Insurance	2
		1	Intellectual Property	2
		1	Interests of Evoqua's Directors and Executive Officers in the Merger	2
		1	Interests of Xylem's Directors and Executive Officers in the Merger	2
		1	International Trade Laws	2
		1	Interpretation	2
		1	Introduction	2
		1	Investment of Exchange Fund	2
8/4/23	10-Q	1	June 30	1
4/11/23	424B3	1	Labor Matters	2
4/2/24	DEF 14A	1	Leadership Development and Compensation Committee Report	2
8/3/23	S-3ASR	1	Legal Matters	1
2/28/24	10-K	1	Legal Proceedings	4
4/11/23	424B3	1	Listing of Xylem Common Stock; Delisting and Deregistration of Evoqua Common Stock	2
		1	Litigation	2
		1	Litigation Relating to the Merger	2
2/28/24	10-K	1	Management's Discussion and Analysis of Financial Condition and Results of Operations	4
5/4/23	10-Q	1	March 31	1
		1	March 31,2023	1
2/28/24	10-K	1	Market for the Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	1
4/11/23	424B3	1	Material U.S. Federal Income Tax Consequences of the Merger	2
		1	Material U.S. Federal Income Tax Considerations of the Merger	2
		1	Merger Agreement, The	2
		1	Merger and the Merger Agreement, The	2
		1	Merger Sub	2
		1	Merger Sub; Parent Vote	2
		1	Merger, The	2
10/31/23	10-Q	1	Mine Safety Disclosure	3
2/28/24	10-K	1	Mine Safety Disclosures	1
10/31/23	10-Q	1	Months Ended	3
5/4/23	10-Q	1	Months Ended March 31, 2023 and 2022 (Unaudited)	1
10/31/23	10-Q	1	Nine	1
4/11/23	424B3	1	No Appraisal Rights	2
		1	No Change of Recommendation	2
		1	No Conflict; Consents and Approvals	2
		1	No Liability	2
		1	No Other Representations or Warranties	2
		1	No Presumption Against Drafting Party	2
		1	No Rights Plan	2
		1	No Solicitation	2
		1	No Third-Party Beneficiaries	2
		1	No Undisclosed Liabilities	2
4/2/24	DEF 14A	1	Non-Qualified Compensation	2
4/11/23	424B3	1	Nonsurvival of Representations and Warranties	2
2/28/24	10-K	1	Note 1 Summary of Significant Accounting Policies	1
4/11/23	424B3	1	Note 1-Basis of Presentation	2
2/28/24	10-K	1	Note 10 Property, Plant and Equipment	1
		1	Note 11 Leases	1
		1	Note 12 Goodwill and Other Intangible Assets	1
		1	Note 13 Derivative Financial Instruments	1
		1	Note 14 Accrued and Other Current Liabilities	1
		1	Note 15 Credit Facilities and Debt	1
		1	Note 16 Post-retirement Benefit Plans	1
		1	Note 17 Share-Based Compensation Plans	1
		1	Note 18 Capital Stock	1
		1	Note 19 Accumulated Other Comprehensive Income (Loss)	1
		1	Note 2	1
		1	Note 2 Recently Issued Accounting Pronouncements	1
4/11/23	424B3	1	Note 2-Xylem and Evoqua reclassification adjustments	2
2/28/24	10-K	1	Note 20 Commitment and Contingencies	1
		1	Note 3 Acquisitions and Divestitures	1
4/11/23	424B3	1	Note 3-Calculation of estimated Merger Consideration and preliminary purchase price allocation	2
2/28/24	10-K	1	Note 4 Revenue	1
4/11/23	424B3	1	Note 4-Transaction Accounting Adjustments to the Unaudited Pro Forma Condensed Combined Balance Sheet	2
2/28/24	10-K	1	Note 5 Restructuring and Asset Impairment Charges	1
4/11/23	424B3	1	Note 5-Transaction Accounting Adjustments to the Unaudited Pro Forma Condensed Combined Statement of Income	2
2/28/24	10-K	1	Note 6 Other Non-Operating Income, Net	1
		1	Note 7 Income Taxes	1
		1	Note 8 Earnings Per Share	1
		1	Note 9 Inventories	1
6/26/23	11-K	1	Notes to Financial Statements	1
10/31/23	10-Q	1	Notes to the Condensed Consolidated Financial Statements (Unaudited)	3
4/11/23	424B3	1	Notes to Unaudited Pro Forma Condensed Combined Financial Information	2
		1	Notices	2
		1	Notification of Certain Matters	2
		1	Officers	2
		1	Opinion of Financial Advisor	2
		1	Opinion of Financial Advisors	2
		1	Opinions of Evoqua's Financial Advisors	2
		1	Opinions of Xylem's Financial Advisors	2
4/2/24	DEF 14A	1	Option Exercises and Stock Vested	2
4/11/23	424B3	1	Organization, Standing and Power	2
2/28/24	10-K	1	Other Information	4
4/11/23	424B3	1	Other Rights	2
4/2/24	DEF 14A	1	Our Executive Compensation Program	2
4/3/23	DEF 14A	1	Outstanding Equity Awards at Fiscal Year-End	1
4/11/23	424B3	1	Ownership of Xylem After Consummation of the Merger	2
3/31/23	S-4/A	1	Part Ii. Information Not Required in Prospectus	1
4/11/23	424B3	1	Parties to the Merger, The	2
4/2/24	DEF 14A	1	Pay-Versus-Performance	2
8/3/23	S-3ASR	1	Plan of Distribution	1
4/2/24	DEF 14A	1	Potential Post-Employment Compensation	2
5/24/23	S-8	1	Power of Attorney (included on signature page hereto)	1
5/24/23	S-8	1	Power of Attorney (included on the signature page hereto)	1
8/3/23	S-3ASR	1	Powers of Attorney of Xylem Inc	1
4/11/23	424B3	1	Preparation of Form S-4 and Proxy Statement; Stockholders' Meetings	2
2/28/24	10-K	1	Principal Accounting Fees and Services	1
4/2/24	DEF 14A	1	Prohibition on Hedging, Pledging and Shorting Xylem Stock	2
2/28/24	10-K	1	Properties	3
4/2/24	DEF 14A	1	Proposal 1: Election of Directors	2
		1	Proposal 2: Ratification of the Appointment of the Independent Registered Public Accounting Firm	2
		1	Proposal 3: Advisory Approval of Named Executive Officer Compensation	2
		1	Proposal 4: Advisory Vote on the Frequency of Future Advisory Votes to Approve Named Executive Officer Compensation	1
4/3/23	DEF 14A	1	Proposal 4: Shareholder Proposal Requesting A Policy Requiring Independent Board Chair	1
		1	Proposals to be Voted on at the 2023 Annual Meeting	1
4/2/24	DEF 14A	1	Proposals to be Voted on at the 2024 Annual Meeting	1
		1	Proxy Statement Summary	2
4/11/23	424B3	1	Public Announcements	2
		1	Purpose of the Evoqua Special Meeting	2
		1	Purpose of the Xylem Meeting	2
2/28/24	10-K	1	Quantitative and Qualitative Disclosures About Market Risk	4
4/11/23	424B3	1	Questions	2
		1	Quorum; Adjournment	2
		1	Recommendation of the Evoqua Board	2
		1	Recommendation of the Evoqua Board and its Reasons for the Merger	2
		1	Recommendation of the Xylem Board	2
		1	Recommendation of the Xylem Board and its Reasons for the Merger	2
		1	Record Date; Shareholders Entitled to Vote	2
		1	Record Date; Stockholders Entitled to Vote	2
5/4/23	10-Q	1	Ree	1
4/11/23	424B3	1	Regulatory Approvals; Consents	2
		1	Regulatory Matters	2
4/2/24	DEF 14A	1	Related Party Transactions	4
2/28/24	10-K	1	Report of Independent Registered Public Accounting Firm	2
4/11/23	424B3	1	Representations and Warranties	2
		1	Required Vote	2
		1	Required Vote of Shareholders	2
		1	Required Vote of Stockholders	2
2/28/24	10-K	1	Reserved	1
4/11/23	424B3	1	Revocation of Proxies	2
2/28/24	10-K	1	Risk Factors	7
4/11/23	424B3	1	Risks Relating to Evoqua's Business	2
		1	Risks Relating to the Combined Company	2
		1	Risks Relating to the Merger	2
		1	Risks Relating to Xylem's Business	2
4/2/24	DEF 14A	1	Role of the Board	2
6/26/23	11-K	1	Schedule of Assets (Held at End of Year) as of December 31	1
4/11/23	424B3	1	SEC Reports; Financial Statements	2
		1	Section 1.1	2
		1	Section 1.2	2
		1	Section 1.3	2
		1	Section 1.4	2
		1	Section 1.5	2
		1	Section 1.6	2
		1	Section 1.7	2
		1	Section 16 Matters	2
		1	Section 2.1	2
		1	Section 2.2	2
		1	Section 2.3	2
		1	Section 2.4	2
		1	Section 3.1	2
		1	Section 3.10	2
		1	Section 3.11	2
		1	Section 3.12	2
		1	Section 3.13	2
		1	Section 3.14	2
		1	Section 3.15	2
		1	Section 3.16	2
		1	Section 3.17	2
		1	Section 3.18	2
		1	Section 3.19	2
		1	Section 3.2	2
		1	Section 3.20	2
		1	Section 3.21	2
		1	Section 3.22	2
		1	Section 3.23	2
		1	Section 3.24	2
		1	Section 3.25	2
		1	Section 3.26	2
		1	Section 3.27	2
		1	Section 3.28	2
		1	Section 3.29	2
		1	Section 3.3	2
		1	Section 3.30	2
		1	Section 3.31	2
		1	Section 3.4	2
		1	Section 3.5	2
		1	Section 3.6	2
		1	Section 3.7	2
		1	Section 3.8	2
		1	Section 3.9	2
		1	Section 4.1	2
		1	Section 4.10	2
		1	Section 4.11	2
		1	Section 4.12	2
		1	Section 4.13	2
		1	Section 4.14	2
		1	Section 4.15	2
		1	Section 4.16	2
		1	Section 4.17	2
		1	Section 4.18	2
		1	Section 4.19	2
		1	Section 4.2	2
		1	Section 4.20	2
		1	Section 4.21	2
		1	Section 4.22	2
		1	Section 4.23	2
		1	Section 4.24	2
		1	Section 4.25	2
		1	Section 4.26	2
		1	Section 4.27	2
		1	Section 4.3	2
		1	Section 4.4	2
		1	Section 4.5	2
		1	Section 4.6	2
		1	Section 4.7	2
		1	Section 4.8	2
		1	Section 4.9	2
		1	Section 5.1	2
		1	Section 5.10	2
		1	Section 5.11	2
		1	Section 5.12	2
		1	Section 5.13	2
		1	Section 5.14	2
		1	Section 5.15	2
		1	Section 5.16	2
		1	Section 5.17	2
		1	Section 5.18	2
		1	Section 5.19	2
		1	Section 5.2	2
		1	Section 5.3	2
		1	Section 5.4	2
		1	Section 5.5	2
		1	Section 5.6	2
		1	Section 5.7	2
		1	Section 5.8	2
		1	Section 5.9	2
		1	Section 6.1	2
		1	Section 6.2	2
		1	Section 6.3	2
		1	Section 6.4	2
		1	Section 7.1	2
		1	Section 7.2	2
		1	Section 7.3	2
		1	Section 7.4	2
		1	Section 7.5	2
		1	Section 8.1	2
		1	Section 8.10	2
		1	Section 8.11	2
		1	Section 8.12	2
		1	Section 8.13	2
		1	Section 8.14	2
		1	Section 8.15	2
		1	Section 8.16	2
		1	Section 8.2	2
		1	Section 8.3	2
		1	Section 8.4	2
		1	Section 8.5	2
		1	Section 8.6	2
		1	Section 8.7	2
		1	Section 8.8	2
		1	Section 8.9	2
2/28/24	10-K	1	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	1
4/11/23	424B3	1	Security Ownership of Certain Beneficial Owners of Evoqua Common Stock and Evoqua Management	2
		1	Security Ownership of Certain Beneficial Owners of Xylem Common Stock and Xylem Management	2
2/28/24	10-K	1	Segment and Geographic Data	1
4/11/23	424B3	1	Selected Historical and Unaudited Pro Forma Combined Per Share Information	2
10/31/23	10-Q	1	Sept	1
		1	September	1
4/11/23	424B3	1	Severability	2
4/2/24	DEF 14A	1	Shareholder Engagement Program	2
2/28/24	10-K	1	Signatures	5
8/4/23	10-Q	1	Six	1
4/11/23	424B3	1	Solicitation of Proxies	2
8/3/23	S-3ASR	1	Special Note Regarding Forward-Looking Statements	1
4/11/23	424B3	1	Specific Performance	2
		1	State Takeover Laws	2
6/26/23	11-K	1	Statement of Changes in Net Assets Available for Benefits for the year ended December 31	1
		1	Statements of Net Assets Available for Benefits as of	1
4/11/23	424B3	1	Stock Exchange Delisting; Deregistration	2
		1	Stock Exchange Listing	2
4/2/24	DEF 14A	1	Stock Ownership	2
4/11/23	424B3	1	Stockholder Litigation	2
		1	Stockholder Proposals	2
		1	Submission to Jurisdiction	2
2/28/24	10-K	1	Subsequent Events	1
4/11/23	424B3	1	Subsidiaries	2
		1	Summary	2
4/2/24	DEF 14A	1	Summary Compensation Table	2
4/11/23	424B3	1	Suppliers	2
4/2/24	DEF 14A	1	Table of Contents	5
4/11/23	424B3	1	Tabulation of Votes	2
		1	Takeover Laws	2
		1	Taxes	2
		1	Termination	2
		1	Termination Fee	2
		1	Termination of the Exchange Fund	2
		1	The Evoqua Special Meeting	2
		1	The Merger	2
		1	The Merger Agreement	2
		1	The Merger and the Merger Agreement	2
		1	The Parties to the Merger	2
		1	The Xylem Special Meeting	2
		1	Transaction Structure	2
		1	Treatment of Options and Other Equity-Based Awards	2
		1	U.S. Federal Securities Law Consequences of the Merger	2
5/4/23	10-Q	1	Unaudited	1
4/11/23	424B3	1	Unaudited Pro Forma Condensed Combined Balance Sheet	2
		1	Unaudited Pro Forma Condensed Combined Financial Information	2
		1	Unaudited Pro Forma Condensed Combined Income Statement	2
3/31/23	S-4/A	1	Undertakings	1
10/31/23	10-Q	1	Unregistered Sales of Equity Securities and Use of Proceeds	3
2/28/24	10-K	1	Unresolved Staff Comments	1
8/3/23	S-3ASR	1	Use of Proceeds	1
4/11/23	424B3	1	Validity of Common Stock	2
		1	Vii	2
4/2/24	DEF 14A	1	Voting and Meeting Information	2
4/11/23	424B3	1	Voting at the Evoqua Special Meeting	2
		1	Voting at the Xylem Special Meeting	2
		1	Voting by Evoqua's Directors and Executive Officers	2
		1	Voting by Xylem's Directors and Executive Officers	2
		1	Voting Rights	2
		1	Waiver of Jury Trial	2
8/3/23	S-3ASR	1	Where You Can Find More Information	3
4/11/23	424B3	1	Withholding Rights	2
		1	Xylem	2
		1	Xylem Inc	2
		1	Xylem Proposal 1-The Share Issuance Proposal	2
		1	Xylem Proposal 2-The Xylem Adjournment Proposal	2
		1	Xylem SEC Filings	2
		1	Xylem Special Meeting	2
		1	Xylem Special Meeting, The	2
2/28/24	10-K	1	Yber Security	1
4/11/23	424B3	1	100	2
2/28/24	10-K	1	102	1
4/11/23	424B3	1	105	2
2/28/24	10-K	1	109	1
		1	112	1
		1	114	1
		1	115	1
		1	117	1
4/11/23	424B3	1	118	2
2/28/24	10-K	1	119	1
		1	120	1
		1	121	1
		1	123	1
		1	124	1
4/11/23	424B3	1	125	2
2/28/24	10-K	1	129	3
4/11/23	424B3	1	130	2
		1	131	2
		1	132	2
		1	133	2
		1	134	2
		1	136	2
		1	137	2
		1	138	2
		1	139	2
		1	140	2
		1	141	2
		1	142	2
		1	143	2
		1	144	2
		1	147	2
		1	151	2
		1	154	2
		1	157	2
		1	164	2
		1	165	2
		1	166	2
		1	168	2
		1	170	2
		1	172	2
		1	173	2
		1	174	2
		1	176	2
		1	177	2
		1	179	2
3/31/23	S-4/A	1	2.1	1
5/4/23	10-Q	1	202	3
4/3/23	DEF 14A	1	2022 Advisory Vote to Approve Executive Compensation	1
		1	2022 Executive Compensation Highlights	1
4/2/24	DEF 14A	1	2023 Advisory Vote to Approve Executive Compensation	1
8/4/23	10-Q	1	2023 and 2022 (Unaudited)	1
		1	2023 and December 31, 2022 (Unaudited)	1
4/2/24	DEF 14A	1	2023 Executive Compensation Highlights	1
4/3/23	DEF 14A	1	2024 Shareholder Proposals	1
4/2/24	DEF 14A	1	2025 Shareholder Proposals	1
4/11/23	424B3	1	203	2
		1	204	2
		1	205	2
		1	206	2
		1	207	2
10/31/23	10-Q	1	30, 2023	1
		1	30, 2023 and 2022 (Unaudited)	1
		1	30,2023 and December 31, 2022 (Unaudited)	1

↑Top

Xylem Inc. DC SEC # 1524472

1,141 Topics within the Past Year Past Two Years Past Three Years Past Four Years Past Five Years Entire Database

Xylem Inc.
DC
SEC # 1524472

1,141 Topics
within the